Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.24.1.1.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 215,650 $ 159,029
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change in unrealized (appreciation) depreciation on investments (25,987) (77,873)
Net realized (gain) loss on investments 9,949 10,731
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts (12,494) 2,505
Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies (16,775) 1,633
Net accretion of discount and amortization of premium, net (27,075) (8,903)
Amortization of deferred financing costs 2,064 1,276
Amortization of debt issuance costs 1,188 295
Amortization of offering costs 453 365
Payment-in-kind interest capitalized (15,722) (4,669)
Payment-in-kind dividends capitalized (761) 0
Purchases of investments (1,416,804) (965,575)
Proceeds from sale of investments and principal repayments 848,237 109,331
Changes in operating assets and liabilities:    
Interest receivable from non-controlled/non-affiliated investments (14,057) (10,782)
Dividend receivable from non-controlled/non-affiliated investments 76 0
Receivable for investments 71,933 (7,922)
Other assets (13,063) 139
Payable for investments purchased 27,604 46,560
Interest payable 1,712 18,153
Due to affiliates 947 4,595
Management fees payable 1,058 11,188
Income based incentive fees payable 5,218 14,248
Capital gains incentive fees payable 5,954 0
Distribution and/or shareholder servicing fees payable 277 74
Accrued expenses and other liabilities (1,496) 11,173
Net cash provided by (used in) operating activities (351,914) (684,429)
Cash flows from financing activities:    
Borrowings on debt 1,267,000 1,470,143
Repayments of debt (1,600,966) (815,960)
Deferred financing costs paid (8,642) (7,233)
Debt issuance costs paid (12,606) (3,646)
Deferred offering costs paid 0 (1,286)
Proceeds from issuance of Common Shares 983,041 152,702
Common Shares repurchased, net of early repurchase deduction (63,474) (9,814)
Distributions paid in cash (100,552) (54,574)
Net cash provided by (used in) financing activities 463,801 730,332
Net increase (decrease) in cash and cash equivalents 111,887 45,903
Cash and cash equivalents, beginning of period 188,775 74,241
Cash and cash equivalents, end of period 300,662 120,144
Supplemental information and non-cash activities:    
Interest paid during the period 81,129 31,810
Taxes paid during the period 1,522 819
Distribution payable 51,674 29,860
Share repurchases accrued but not paid 59,526 25,769
Reinvestment of distributions during the period 69,008 37,456
Non-cash purchases of investments 2,016 19,124
Non-cash sales of investments $ (2,016) $ (19,124)